New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
Editor's Top Picks
Minocycline Stroke Trial Debate Highlights Neuroprotection Research Challenges
Scientific debate in The Lancet highlights persistent challenges in stroke neuroprotection research following criticism of the EMPHASIS minocycline trial. Researchers…
Submit Your Paper →
More form New Studies
Belgian Study Reveals Surge in Serotype 4 Pneumococcal Disease Among Young Men
Belgian researchers document rapid increase in serotype 4 invasive pneumococcal disease among vulnerable young men…
Intermittent Fasting Rewires Brain and Gut Microbiome, New Study Reveals
New research reveals intermittent fasting triggers coordinated changes in brain appetite control regions and gut…
MAGE-A4/MAGE-A8-Targeted Bispecific T Cell Engager Shows Promise in Refractory Solid Tumors
Novel bispecific T cell engager IMA401 targeting MAGE-A4/MAGE-A8 shows encouraging safety and preliminary efficacy in…
Triple-Drug Therapy Extends Survival in Advanced Prostate Cancer Trial
Triple-drug combination therapy significantly improved survival outcomes in advanced prostate cancer trial. The approach combines…
Multi-country study reveals critical gaps in Chagas disease data systems across Bolivia and Paraguay
New research identifies critical gaps in Chagas disease surveillance systems across Bolivia and Paraguay. The…